140 related articles for article (PubMed ID: 12759928)
1. SOCS1 methylation in patients with newly diagnosed acute myeloid leukemia.
Chen CY; Tsay W; Tang JL; Shen HL; Lin SW; Huang SY; Yao M; Chen YC; Shen MC; Wang CH; Tien HF
Genes Chromosomes Cancer; 2003 Jul; 37(3):300-5. PubMed ID: 12759928
[TBL] [Abstract][Full Text] [Related]
2. Association between methylation of tumor suppressor gene SOCS1 and acute myeloid leukemia.
Zhang XH; Yang L; Liu XJ; Zhan Y; Pan YX; Wang XZ; Luo JM
Oncol Rep; 2018 Aug; 40(2):1008-1016. PubMed ID: 29916533
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic dysregulation of the Jak/STAT pathway by frequent aberrant methylation of SHP1 but not SOCS1 in acute leukaemias.
Chim CS; Wong AS; Kwong YL
Ann Hematol; 2004 Aug; 83(8):527-32. PubMed ID: 14762685
[TBL] [Abstract][Full Text] [Related]
4. Dormant tumor cells develop cross-resistance to apoptosis induced by CTLs or imatinib mesylate via methylation of suppressor of cytokine signaling 1.
Saudemont A; Hamrouni A; Marchetti P; Liu J; Jouy N; Hetuin D; Colucci F; Quesnel B
Cancer Res; 2007 May; 67(9):4491-8. PubMed ID: 17483365
[TBL] [Abstract][Full Text] [Related]
5. Gfi-1 is the transcriptional repressor of SOCS1 in acute myeloid leukemia cells.
Lee MC; Kuo YY; Chou WC; Hou HA; Hsiao M; Tien HF
J Leukoc Biol; 2014 Jan; 95(1):105-15. PubMed ID: 24018353
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic inactivation of suppressors of cytokine signalling in Philadelphia-negative chronic myeloproliferative disorders.
Capello D; Deambrogi C; Rossi D; Lischetti T; Piranda D; Cerri M; Spina V; Rasi S; Gaidano G; Lunghi M
Br J Haematol; 2008 May; 141(4):504-11. PubMed ID: 18318760
[TBL] [Abstract][Full Text] [Related]
7. [Effect of SOCS1 Gene on Growth Inhibition of Acute Myeloid Leukemia Cells Mediated by JAK2/STAT Signaling Pathway].
Zhang XH; Luo JM; Yang L; Liu XJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Oct; 28(5):1496-1503. PubMed ID: 33067944
[TBL] [Abstract][Full Text] [Related]
8. SOCS1 and SHP1 hypermethylation in multiple myeloma: implications for epigenetic activation of the Jak/STAT pathway.
Chim CS; Fung TK; Cheung WC; Liang R; Kwong YL
Blood; 2004 Jun; 103(12):4630-5. PubMed ID: 14976049
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic alteration of the SOCS1 gene in chronic myeloid leukaemia.
Liu TC; Lin SF; Chang JG; Yang MY; Hung SY; Chang CS
Br J Haematol; 2003 Nov; 123(4):654-61. PubMed ID: 14616969
[TBL] [Abstract][Full Text] [Related]
10. Clinico-biological significance of suppressor of cytokine signaling 1 expression in acute myeloid leukemia.
Hou HA; Lu JW; Lin TY; Tsai CH; Chou WC; Lin CC; Kuo YY; Liu CY; Tseng MH; Chiang YC; Peng YL; Tang JL; Gong Z; Lin LI; Tien HF
Blood Cancer J; 2017 Jul; 7(7):e588. PubMed ID: 28753595
[TBL] [Abstract][Full Text] [Related]
11. SOCS1 is a suppressor of liver fibrosis and hepatitis-induced carcinogenesis.
Yoshida T; Ogata H; Kamio M; Joo A; Shiraishi H; Tokunaga Y; Sata M; Nagai H; Yoshimura A
J Exp Med; 2004 Jun; 199(12):1701-7. PubMed ID: 15197228
[TBL] [Abstract][Full Text] [Related]
12. Distinct activities of suppressor of cytokine signaling (SOCS) proteins and involvement of the SOCS box in controlling G-CSF signaling.
van de Geijn GJ; Gits J; Touw IP
J Leukoc Biol; 2004 Jul; 76(1):237-44. PubMed ID: 15107455
[TBL] [Abstract][Full Text] [Related]
13. Promoter DNA methylation and expression levels of HOXA4, HOXA5 and MEIS1 in acute myeloid leukemia.
Musialik E; Bujko M; Kober P; Grygorowicz MA; Libura M; Przestrzelska M; Juszczyński P; Borg K; Florek I; Jakóbczyk M; Siedlecki JA
Mol Med Rep; 2015 May; 11(5):3948-54. PubMed ID: 25585874
[TBL] [Abstract][Full Text] [Related]
14. SOCS proteins: negative regulators of cytokine signaling.
Krebs DL; Hilton DJ
Stem Cells; 2001; 19(5):378-87. PubMed ID: 11553846
[TBL] [Abstract][Full Text] [Related]
15. Differential hypermethylation of SOCS genes in ovarian and breast carcinomas.
Sutherland KD; Lindeman GJ; Choong DY; Wittlin S; Brentzell L; Phillips W; Campbell IG; Visvader JE
Oncogene; 2004 Oct; 23(46):7726-33. PubMed ID: 15361843
[TBL] [Abstract][Full Text] [Related]
16. SOCS1 and SHP1 hypermethylation in mantle cell lymphoma and follicular lymphoma: implications for epigenetic activation of the Jak/STAT pathway.
Chim CS; Wong KY; Loong F; Srivastava G
Leukemia; 2004 Feb; 18(2):356-8. PubMed ID: 14614518
[No Abstract] [Full Text] [Related]
17. How frequent is SOCS1 methylation in acute myeloid leukaemia?
Chim CS; Kwong YL
Br J Haematol; 2004 Dec; 127(5):609-11. PubMed ID: 15566368
[No Abstract] [Full Text] [Related]
18. Hypermethylation associated with inactivation of the SOCS-1 gene, a JAK/STAT inhibitor, in human hepatoblastomas.
Nagai H; Naka T; Terada Y; Komazaki T; Yabe A; Jin E; Kawanami O; Kishimoto T; Konishi N; Nakamura M; Kobayashi Y; Emi M
J Hum Genet; 2003; 48(2):65-9. PubMed ID: 12601549
[TBL] [Abstract][Full Text] [Related]
19. Hypermethylation of the suppressor of cytokine signalling-1 (SOCS-1) in myelodysplastic syndrome.
Brakensiek K; Länger F; Schlegelberger B; Kreipe H; Lehmann U
Br J Haematol; 2005 Jul; 130(2):209-17. PubMed ID: 16029449
[TBL] [Abstract][Full Text] [Related]
20. CUEDC2, a novel interacting partner of the SOCS1 protein, plays important roles in the leukaemogenesis of acute myeloid leukaemia.
Wu QY; Zhu YY; Liu Y; Wei F; Tong YX; Cao J; Zhou P; Niu MS; Li ZY; Zeng LY; Li F; Xu KL
Cell Death Dis; 2018 Jul; 9(7):774. PubMed ID: 29991678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
